Synergy Asset Management’s Boston Scientific BSX Stock Holding History

Synergy Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.52M	Buy	129,318 +23,865	+23%	+$1.3M	0.52%	36
2026 Q1	$6.62M	Sell	105,453 -142,657	-57%	-$11.4M	0.7%	29
2025 Q4	$23.7M	Sell	248,110 -245,213	-50%	-$24M	2.46%	11
2025 Q3	$48.3M	Buy	493,323 +479,593	+3,493%	+$49.7M	1.75%	13
2025 Q2	$1.47M	Buy	13,730 +1,801	+15%	+$182K	0.17%	74
2025 Q1	$1.2M	Buy	+11,929	New	+$1.2M	0.15%	85
2022 Q4	–	Sell	-92,995	Closed	-$3.6M	–	112
2022 Q3	$3.6M	Buy	+92,995	New	+$3.73M	0.97%	25

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Synergy Asset Management's BSX Position: Q2 2026 in Review

Synergy Asset Management increased its Boston Scientific (BSX) stake by 23% in Q2 2026, buying an estimated $1.3M and bringing the position to 129,318 shares worth $5.52M. The position accounts for 0.52% of the portfolio, ranked #36.

Synergy Asset Management first reported a position in BSX in Q3 2022 and has held it in 7 quarters since. The position peaked at $48.3M in Q3 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Synergy Asset Management held 129,318 shares of Boston Scientific worth $5.52M as of Q2 2026.
Synergy Asset Management bought 23,865 Boston Scientific shares in Q2 2026, an estimated $1.3M.
Boston Scientific made up 0.52% of Synergy Asset Management's portfolio in Q2 2026, its #36 holding.
Synergy Asset Management first reported a position in Boston Scientific in Q3 2022 and has held it in 7 quarters since.
Synergy Asset Management's Boston Scientific position peaked at $48.3M in Q3 2025.
1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Synergy Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.